Dow Down0.22% Nasdaq Up0.14%

Ironwood Pharmaceuticals, Inc. (IRWD)

-NasdaqGS
12.17 Down 0.31(2.48%) Aug 22, 4:00PM EDT
|After Hours : 12.17 Up 0.01 (0.08%) Aug 22, 4:27PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 6,840   14,605   5,031   4,932  
Cost of Revenue10,518  1,924  533  2,021  
Gross Profit (3,678) 12,681   4,498   2,911  
Operating Expenses
Research Development22,142  27,144  22,516  23,016  
Selling General and Administrative29,299  29,924  28,720  36,446  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (55,119) (44,387) (46,738) (56,551)
Income from Continuing Operations
Total Other Income/Expenses Net65  44  50  41  
Earnings Before Interest And Taxes(55,054)(44,343)(46,688)(56,510)
Interest Expense5,303  5,283  5,298  5,265  
Income Before Tax(60,357)(49,626)(51,986)(61,775)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(60,357)(49,626)(51,986)(61,775)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (60,357) (49,626) (51,986) (61,775)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (60,357) (49,626) (51,986) (61,775)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.